8,26 Those with sickle mobile trait are authorized for full blood donation by WHO; nonetheless, with specific limits on its use, including to neonates and recipients with sickle cell illness. Crimson mobile enzyme deficiencies with a identified heritage of hemolysis, including the most commonly noticed glucose-six–phosphate dehydrogenase (G6PD) d